Related references
Note: Only part of the references are listed.Enigmatic MELK: The controversy surrounding its complex role in cancer
Ian M. McDonald et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Synthesis and Evaluation of New Bifunctional Chelators with Phosphonic Acid Arms for Gallium-68 Based PET Imaging in Melanoma
Yongkang Gai et al.
BIOCONJUGATE CHEMISTRY (2018)
MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells
Reto S. Kohler et al.
GYNECOLOGIC ONCOLOGY (2017)
Synthesis and Preclinical Evaluation of 18F-PEG3-FPN for the Detection of Metastatic Pigmented Melanoma
Xiaodong Xu et al.
MOLECULAR PHARMACEUTICS (2017)
The target landscape of clinical kinase drugs
Susan Klaeger et al.
SCIENCE (2017)
Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
Suyoun Chung et al.
ONCOTARGET (2016)
Borealin dimerization mediates optimal CPC checkpoint function by enhancing localization to centromeres and kinetochores
Michael E. Bekier et al.
NATURE COMMUNICATIONS (2015)
Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer
Suyoun Chung et al.
Oncotarget (2015)
MELK-a conserved kinase: functions, signaling, cancer, and controversy
Ranjit Ganguly et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2015)
Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway
Tao Du et al.
MOLECULAR CANCER (2014)
Maternal Embryonic Leucine Zipper Kinase: Key Kinase for Stem Cell Phenotype in Glioma and Other Cancers
Ranjit Ganguly et al.
MOLECULAR CANCER THERAPEUTICS (2014)
MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
Yubao Wang et al.
ELIFE (2014)
Role of PET quantitation in the monitoring of cancer response to treatment: review of approaches and human clinical trials
Robert K. Doot et al.
CLINICAL AND TRANSLATIONAL IMAGING (2014)
Maternal Embryonic Leucine Zipper Kinase (MELK): A Novel Regulator in Cell Cycle Control, Embryonic Development, and Cancer
Pengfei Jiang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis
Mar Carmena et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
SAICAR Stimulates Pyruvate Kinase Isoform M2 and Promotes Cancer Cell Survival in Glucose-Limited Conditions
Kirstie E. Keller et al.
SCIENCE (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
A single-centre chart review exploring the adjusted association between breast cancer phenotype and prognosis
C. Hamm et al.
Current Oncology (2011)
Maternal Embryonic Leucine Zipper Kinase Is Upregulated and Required in Mammary Tumor-Initiating Cells In vivo
Lionel W. Hebbard et al.
CANCER RESEARCH (2010)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
[C-11]Gefitinib ([C-11]Iressa): Radiosynthesis, In Vitro Uptake, and In Vivo Imaging of Intact Murine Fibrosarcoma
Ming-Rong Zhang et al.
MOLECULAR IMAGING AND BIOLOGY (2010)
Triple-negative breast cancer: disease entity or title of convenience?
Lisa Carey et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Pattern of metastatic spread in triple-negative breast cancer
Rebecca Dent et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Positron Emission Tomography (PET) Imaging with [11C]-Labeled Erlotinib: A Micro-PET Study on Mice with Lung Tumor Xenografts
Ashfaque A. Memon et al.
CANCER RESEARCH (2009)
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Impact of triple negative phenotype on breast cancer prognosis
Henry G. Kaplan et al.
BREAST JOURNAL (2008)
Evaluation of [F-18]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors
Helen Su et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers
Scott L. Carter et al.
NATURE GENETICS (2006)
Immobilized metal ion affinity-based fluorescence polarization (IMAP): Advances in kinase screening
JR Sportsman et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2004)
Cell cycle regulation of pEg3, a new Xenopus protein kinase of the KIN1/PAR-1/MARK family
J Blot et al.
DEVELOPMENTAL BIOLOGY (2002)
Share Paper
